Differential proteomic analysis of the anti-proliferative effect of glucocorticoid hormones in ST1 rat glioma cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 2, 2007, Pages 137-148

  Demasi, Marcos A A ^a   Montor, Wagner R ^a   Ferreira, Gabriela B ^a   Pimenta, Daniel C ^b   Labriola, Letícia ^a   Sogayar, Mari C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Annexin 2; Anti proliferative effect; Glucocorticoid hormones; Proteomic analysis

Indexed keywords

GLUCOCORTICOID; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HYDROCORTISONE; LIPOCORTIN 2; MESSENGER RNA; NUCLEAR PROTEIN; POLYPEPTIDE; UBIQUITIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARCINOGENIC ACTIVITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLIOMA CELL; HORMONE ACTION; MASS SPECTROMETRY; NONHUMAN; PEPTIDE ANALYSIS; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; RAT; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TUMOR CELL CULTURE; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; ANNEXIN A2; CELL PROLIFERATION; GLIOMA; GLUCOCORTICOIDS; HYDROCORTISONE; MASS SPECTROMETRY; NUCLEAR PROTEINS; PEPTIDE MAPPING; PROTEOMICS; RATS; TUMOR CELLS, CULTURED;

RATTUS;

EID: 33846415873     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.08.004     Document Type: Article

References (69)

1. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., and Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9 13 (1995) 1608-1621
2. Rogatsky I., Trowbridge J.M., and Garabedian M.J. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol. Cell Biol. 17 6 (1997) 3181-3193
3. Crossin K.L., Tai M.H., Krushel L.A., Mauro V.P., and Edelman G.M. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc. Natl. Acad. Sci. U.S.A. 94 6 (1997) 2687-2692
4. Cha H.H., Cram E.J., Wang E.C., Huang A.J., Kasler H.G., and Firestone G.L. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells. J. Biol. Chem. 273 4 (1998) 1998-2007
5. Goya L., Maiyar A.C., Ge Y., and Firestone G.L. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha. Mol. Endocrinol. 7 9 (1993) 1121-1132
6. Shalhoub V., Conlon D., Tassinari M., Quinn C., Partridge N., Stein G.S., and Lian J.B. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J. Cell. Biochem. 50 4 (1992) 425-440
7. Ramos R.A., Meilandt W.J., Wang E.C., and Firestone G.L. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant. FASEB J. 13 1 (1999) 169-180
8. Greenberg A.K., Hu J., Basu S., Hay J., Reibman J., Yie T.A., Tchou-Wong K.M., Rom W.N., and Lee T.C. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am. J. Respir. Cell Mol. Biol. 27 3 (2002) 320-328
9. Kaup B., Schindler I., Knupfer H., Schlenzka A., Preiss R., and Knupfer M.M. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J. Neurooncol. 51 2 (2001) 105-110
10. Renner K., Ausserlechner M.J., and Kofler R. A conceptual view on glucocorticoid-induced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia. Curr. Mol. Med. 3 8 (2003) 707-717
11. Addeo R., Casale F., Caraglia M., D'Angelo V., Crisci S., Abbruzzese A., Di Tullio M.T., and Indolfi P. Glucocordicoids induce g(1) arrest of lymphoblastic cells through retinoblastoma protein rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol. Ther. 3 (2004) 470-476
12. Almawi W.Y., and Melemedjian O.K. Molecular mechanisms of glucocorticoid anti-proliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J. Leuk. Biol. 71 1 (2002) 9-15
13. Whitfield G.K., Jurutka P.W., Haussler C.A., and Haussler M.R. Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J. Cell. Biochem. 75 S32 (1999) 110-122
14. Kinyamu H.K., and Archer T.K. Modifying chromatin to permit steroid hormone receptor-dependent transcription. Biochim. Biophys. Acta 1677 1-3 (2004) 30-45
15. Gottlicher M., Heck P., and Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76 (1998) 480-489
16. Grasso R.J. Transient inhibition of cell proliferation in rat glioma monolayer cultures by cortisol. Cancer Res. 6 7 Pt. 1 (1976) 2408-2414
17. Armelin M.C.S., and Armelin H.A. Glucocorticoid hormone modulation of both cell surface and cytoskeleton related to growth control of rat glioma cells. J. Cell Biol. 97 (1983) 459-465
18. Armelin M.C.S., Stocco R.C., and Armelin H.A. Control of rat glioma cell proliferation: uncouplin of the inhibitory effects of hydrocortisone hormone in suspension and monolayer cultures. J. Cell Biol. 97 (1983) 455-458
19. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differentiated rat glial cell strain in tissue culture. Science 161 839 (1968) 370-371
20. Urban G., Golden T., Aragon I.V., Cowsert L., Cooper S.R., Dean N.M., and Honkanen R.E. Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression. J. Biol. Chem. 278 (2003) 9747-9753
21. Laz E.V., Wiwi C.A., and Waxman D.J. Sexual dimorphism of rat liver nuclear proteins: regulatory role of growth hormone. Mol. Cell. Proteomics 3 12 (2004) 1170-1180
22. Waghray A., Feroze F., Schober M.S., Yao F., Wood C., Puravs E., Krause M., Hanash S., and Chen Y.Q. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 1 10 (2001) 1327-1338
23. Dignam J.D., Libovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
24. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 9 (1991) 2499
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
26. Capco D.G., and Penman S. Mitotic architecture of the cell: the filament networks of the nucleus and cytoplasm. J. Cell Biol. 96 3 (1983) 896-906
27. Neuhoff V., Arold N., Taube D., and Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9 6 (1998) 255-262
28. Gharahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., and Mische S.M. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20 3 (1999) 601-605
29. Courchesne P.L., and Patterson S.D. Identification of proteins by matrix-assisted laser desorption/ionization mass spectrometry using peptide and fragment ion masses. Meth. Mol. Biol. 112 (1999) 487-511
30. Tuloup M., Hernandez C., Coro I., Hoogland C., Binz P.A., and Appel R.D. Aldente and BioGraph: an improved peptide mass fingerprinting protein identification environment. Swiss Proteomics Society 2003 Congress: Understanding Biological Systems through Proteomics, December 2-4 (2003) 174-176 (FontisMedia, ISBN: 2-88476-004-0)
31. Vedoy C.G., and Sogayar M.C. Isolation and characterization of genes associated with the anti-tumor activity of glucocorticoids. Mol. Brain Res. 106 (2002) 57-69
32. Eberhard D.A., Karns L.R., VandenBerg S.R., and Creutz C.E. Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J. Cell Sci. 114 (2001) 3155-3166
33. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6 6 (2005) 449-461
34. Fey E.G., Capco D.G., Krochmalnic G., and Penman S. Epithelial structure revealed by chemical dissection and unembedded electron microscopy. J. Cell Biol. 99 (1984) 203s-208s
35. Albig W., and Doenecke D. The human histone gene cluster at the D6S105 locus. Hum. Genet. 101 3 (1997) 284-294
36. Collingwood T.N., Urnov F.D., and Wolffe A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endocrinol. 23 3 (1999) 255-275
37. Hernandez M.C., Andres-Barquin P.J., Martinez S., Bulfone A., Rubenstein J.L., and Israel M.A. ENC-1: a novel mammalian kelch-related gene specifically expressed in the nervous system encodes an actin-binding protein. J. Neurosci. 17 9 (1997) 3038-3051
38. Kim T.A., Lim J., Ota S., Raja S., Rogers R., Rivnay B., Avraham H., and Avraham S. NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation. J. Cell Biol. 141 3 (1998) 553-566
39. Rahm M., Hultgardh-Nilsson A., Jiang W.Q., Sejersen T., and Ringertz N.R. Intracellular distribution of the c-fos antigen during the cell cycle. J. Cell Physiol. 143 3 (1990) 475-482
40. Renz M., Verrier B., Kurz C., and Muller R. Chromatin association and DNA binding properties of the c-fos proto-oncogene product. Nucleic Acids Res. 15 1 (1987) 277-292
41. Loidl P., and Eberharter A. Nuclear matrix and the cell cycle. Int. Rev. Cytol. 162B (1995) 377-403
42. Blüher M., Wilson-Fritch L., Leszyk J., Laustsen P.G., Corvera S., and Kahn C.R. Role of insulin action and cell size on protein expression patterns in adipocytes. J. Biol. Chem. 279 30 (2004) 31902-31909
43. Solomon S.S., Buss N., Shull J., Monnier S., Majumdar G., Wu J., and Gerling I.C. Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance. J. Lab. Clin. Med. 145 5 (2005) 275-283
44. Matunis M.J., Xing J., and Dreyfuss G. The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization. Nucleic Acids Res. 22 6 (1994) 1059-1067
45. Ma A.S., Moran-Jones K., Shan J., Munro T.P., Snee M.J., Hoek K.S., and Smith R. Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein. J. Biol. Chem. 277 (2002) 18010-18020
46. Caputi M., and Zahler A.Z. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H′/F/2H9 family. J. Biol. Chem. 276 47 (2001) 43850-43859
47. Yoshida T., Makino Y., and Tamura T. Association of the rat heterogeneous nuclear RNA-ribonucleoprotein F with TATA-binding protein. FEBS Lett. 457 2 (1999) 251-254
48. Sun L., and Chen Z.J. The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. 16 2 (2004) 119-126
49. Kinyamu H.K., Chen J., and Archer T.K. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J. Mol. Endocrinol. 34 2 (2005) 281-297
50. Voges D., Zwickl P., and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68 (1999) 1015-1068
51. Sakao Y., Kawai T., Takeuchi O., Copeland N.G., Gilbert D.J., Jenkins N.A., Takeda K., and Akira S. Mouse proteasomal ATPases Psmc3 and Psmc4: genomic organization and gene targeting. Genomics 67 1 (2000) 1-7
52. Liu J.W., Shen J.J., Tanzillo-Swarts A., Bhatia B., Maldonado C.M., Person M.D., Lau S.S., and Tang D.G. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22 10 (2003) 1475-1485
53. Jindal H.K., Chaney W.G., Anderson C.W., Davis R.G., and Vishwanatha J.K. The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J. Biol. Chem. 266 8 (1991) 5169-5176
54. Filipenko N.R., MacLeod T.J., Yoon C.S., and Waisman D.M. Annexin A2 is a novel RNA-binding protein. J. Biol. Chem. 279 10 (2004) 8723-8731
55. Wilkinson B., and Gilbert H.F. Protein disulfide isomerase. Biochim. Biophys. Res. 1699 (2004) 35-44
56. Haynes L.P., Tepikin A.V., and Burgoyne R.D. Calcium-binding protein 1 is an inhibitor of agonist-evoked, inositol 1,4,5-trisphosphate-mediated calcium signaling. J. Biol. Chem. 279 1 (2004) 547-555
57. Schroer T.A. Dynactin. Annu. Rev. Cell. Dev. Biol. 20 (2004) 759-779
58. Combaret L., Taillandier D., Dardevet D., Bechet D., Ralliere C., Claustre A., Grizard J., and Attaix D. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Biochem. J. 378 Pt 1 (2004) 239-246
59. Marinovic A.C., Zheng B., Mitch W.E., Price S.R., and Ubiquitin. (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J. Biol. Chem. 277 19 (2002) 16673-16681
60. Morimoto T., Ide T., Ihara Y., Tamura A., and Kirino T. Transient ischemia depletes free ubiquitin in the gerbil hippocampal CA1 neurons. Am. J. Pathol. 148 1 (1996) 249-257
61. Tan Z., Qu W., Tu W., Liu W., Baudry M., and Schreiber S.S. p53 accumulation due to down-regulation of ubiquitin: relevance for neuronal apoptosis. Cell Death Diff. 7 7 (2000) 675-681
62. Tan Z., Tu W., and Schreiber S.S. Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death. Brain Res. Mol. Brain Res. 91 1-2 (2001) 179-188
63. Almawi W.Y., Saouda M.S., Stevens A.C., Lipman M.L., Barth C.M., and Strom T.B. Partial mediation of glucocorticoid anti-proliferative effects by lipocortins. J. Immunol. 157 12 (1996) 5231-5239
64. Chiang Y., Schneiderman M.H., and Vishwanatha J.K. Annexin II expression is regulated during mammalian cell cycle. Cancer Res. 53 24 (1993) 6017-6021
65. Keutzer J.C., and Hirschhorn R.R. The growth-regulated gene 1B6 is identified as the heavy chain of calpactin I. Exp. Cell Res. 188 1 (1990) 153-159
66. Chiang Y., Rizzino A., Sibenaller Z.A., Wold M.S., and Vishwanatha J.K. Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol. Cell Biochem. 199 1-2 (1999) 139-147
67. Harder T., Kellner R., Parton R.G., and Gruenberg J. Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol. Biol. Cell. 8 3 (1997) 533-545
68. Guzman-Aranguez A., Olmo N., Turnay J., Lecona E., Perez-Ramos P., Lopez de Silanes I., and M.A. Lizarbe M.A. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J. Cell Biochem. 94 1 (2005) 178-193
69. Ransom R.F., Vega-Warner V., Smoyer W.E., and Klein J. Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int. 67 4 (2005) 1275-1285